American Portfolios Advisors’s Therapix Biosciences Ltd. TRPX Stock Holding History

American Portfolios Advisors’s Portfolio TRPX Stock Details TRPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-200	Closed	-$474	–	2951
2019 Q3	$474	Hold	200	–	–	﹤0.01%	2719
2019 Q2	$500	Hold	200	–	–	﹤0.01%	2650
2019 Q1	$626	Buy	+200	New	+$813	﹤0.01%	2512

Other funds holding TRPX

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Portfolios Advisors's TRPX Position: Q4 2019 in Review

American Portfolios Advisors sold out of Therapix Biosciences Ltd. (TRPX) in Q4 2019, closing a stake of 200 shares — an estimated $474 sold.

American Portfolios Advisors first reported a position in TRPX in Q1 2019 and held it in 3 quarters. The position peaked at $626 in Q1 2019. 4 funds tracked by Wall St. Rank hold TRPX as of Q4 2019.

American Portfolios Advisors reported no remaining Therapix Biosciences Ltd. position as of Q4 2019 after selling out during the quarter.
American Portfolios Advisors sold 200 Therapix Biosciences Ltd. shares in Q4 2019, an estimated $474.
American Portfolios Advisors first reported a position in Therapix Biosciences Ltd. in Q1 2019 and held it in 3 quarters.
American Portfolios Advisors's Therapix Biosciences Ltd. position peaked at $626 in Q1 2019.
4 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q4 2019.

Based on American Portfolios Advisors's 13F filing for Q4 2019, filed 24 Mar 2023.